Approval · Notice of Compliance 37723 · 2026
MARCAINE: Notice of Compliance 37723
Issued June 17, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37723
- Date
- June 17, 2026
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a primary container closure system
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MARCAINE | Not yet assigned | — |
Medicinal ingredients
- BUPIVACAINE HYDROCHLORIDE 5 MG per ML
- BUPIVACAINE HYDROCHLORIDE 7.5 MG per ML